ImmuneSpec (Private limited company)
ImmuneSpec is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0797.707.610. It was founded on 27-01-2023. Its registered office is in Niel. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 2 638 403 and a loss of € 201 723. These accounts report 5.7 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of ImmuneSpec
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -201 723-159 % | € -77 917+80 % | € -397 068 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 2 638 403+13 % | € 2 340 065+22 % | € 1 917 922 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 3 535 158+11 % | € 3 178 749-1 % | € 3 208 974 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 883 559+27 % | € 696 858+1 252 % | € 51 531 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 5.7+68 % | 3.4+100 % | 1.7 |
Financial estimate
- 2 Shareholders
- 4 Board links
Similar companies
Other companies in the same activity in Niel.
| Company | Town |
|---|---|
| ETHERNA IMMUNOTHERAPIES | 2845 Niel |
| OXYPOINT | 2845 Niel |
| Clinical Projects International | 2845 Niel |
| iFLUX | 2845 Niel |
| anicells | 2845 Niel |
| GRAND MEDICAL (EUROPE) | 2845 Niel |
| SYNAPTIX | 2845 Niel |
| EUROPEAN RESPIRATORY CLUSTER ANTWERP | 2845 Niel |
Frequently asked questions
Is ImmuneSpec still active? Yes. The Crossroads Bank for Enterprises lists ImmuneSpec as active.
What is the VAT number of ImmuneSpec? The VAT number of ImmuneSpec is BE 0797.707.610.
When was ImmuneSpec founded? ImmuneSpec was founded on 27-01-2023.
What is the address of ImmuneSpec? The current registered office of ImmuneSpec is Galileilaan 18, 2845 Niel.
When did ImmuneSpec last file annual accounts? The latest annual accounts of ImmuneSpec were filed on 08-06-2026.
Does ImmuneSpec file its annual accounts on time? Yes. ImmuneSpec filed its annual accounts within the legal deadline for each of its last 3 financial years.
How many employees does ImmuneSpec have? ImmuneSpec employs 5.7 full-time equivalents according to its most recent annual accounts.
Is ImmuneSpec financially healthy? Addrly gives ImmuneSpec a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is ImmuneSpec profitable? The annual accounts of ImmuneSpec for 2025 show a loss of € 201 723.
What is the equity of ImmuneSpec? The equity of ImmuneSpec was € 2 638 403 at the close of the 2025 financial year.
Who are the directors of ImmuneSpec? The annual accounts of ImmuneSpec record 8 mandates. The names, roles and dates are visible with a free account.
Can ImmuneSpec receive Peppol e-invoices? Yes. ImmuneSpec is registered on the Peppol network and can receive structured electronic invoices.
What does ImmuneSpec do? The main activity of ImmuneSpec is: Scientific research and development.